Latest Articles
NR4A1 Acts as a Nutrient Sensor That Inhibits the Effects of Aging.
Orphan nuclear receptor 4A1 (NR4A1) is a member of the NR4A subfamily that was initially discovered as an intermediate early gene expressed in response to stressors, including inflammatory agents. This …
Published: Aug. 21, 2025, midnight
DRIVE-KG: Enhancing variant-phenotype association discovery in understudied complex diseases using heterogeneous knowledge graphs.
Multi-omics data are instrumental in obtaining a comprehensive picture of complex biological systems. This is particularly useful for women's health conditions, such as endometriosis which has been historically understudied despite …
Published: Aug. 21, 2025, midnight
Gabby Thomas’ Training Partner Shamed at Diamond League, Expresses Frustration: ”Expect the Same” - EssentiallySports
Gabby Thomas’ Training Partner Shamed at Diamond League, Expresses Frustration: ”Expect the Same” EssentiallySports
Published: Aug. 20, 2025, 11:24 p.m.
Endometriosis affects more systems in women's bodies than previously understood - Medical Xpress
Endometriosis affects more systems in women's bodies than previously understood Medical Xpress
Published: Aug. 20, 2025, 5:44 p.m.
The Samsung Galaxy Ring is down to its lowest price ever at Amazon - Mashable
The Samsung Galaxy Ring is down to its lowest price ever at Amazon Mashable
Published: Aug. 20, 2025, 5:11 p.m.
Endometriosis affects more systems in women’s bodies than previously understood - Penn State University
Endometriosis affects more systems in women’s bodies than previously understood Penn State University
Published: Aug. 20, 2025, 4:11 p.m.
BioNTech’s Promising Phase III Study on Recurrent Endometrial Cancer - TipRanks
BioNTech’s Promising Phase III Study on Recurrent Endometrial Cancer TipRanks
Published: Aug. 20, 2025, 4:07 p.m.
AstraZeneca’s Phase III Study on Endometrial Cancer: A Potential Game Changer? - TipRanks
AstraZeneca’s Phase III Study on Endometrial Cancer: A Potential Game Changer? TipRanks
Published: Aug. 20, 2025, 4:07 p.m.
Sutro Biopharma’s STRO-002: A Promising Phase 1 Trial Update in Ovarian and Endometrial Cancers - TipRanks
Sutro Biopharma’s STRO-002: A Promising Phase 1 Trial Update in Ovarian and Endometrial Cancers TipRanks
Published: Aug. 20, 2025, 4:06 p.m.
ESSE Care Hosts Inaugural Summer Soirée: Uniting NYC's Brightest Healthcare Providers at the Shafer - pharmiweb.com
ESSE Care Hosts Inaugural Summer Soirée: Uniting NYC's Brightest Healthcare Providers at the Shafer pharmiweb.com
Published: Aug. 20, 2025, 1:28 p.m.
Link copied to clipboard!